A Skeptical Read of the “AI-Alone Medicine” Argument https://jamanetwork.com/journals/jama/fullarticle/2852952 There’s a comfortable consensus in medicine about artificial intelligence: the machine assists, the physician decides. The AMA even rebranded it “augmented intelligence” to keep the human firmly in charge. A recent JAMA Viewpoint by Ezekiel Emanuel and colleagues sets out to demolish that consensus. Its claimContinueContinue reading “When the Doctor Becomes Optional 😳”
Category Archives: Diabetes
The Ozempic Era Grows Up
What the Latest NEJM Review Gets Right, and Glosses Over A Critique and Summary of the GLP-1 Receptor Agonists Review by Clifford J. Rosen and Julie R. Ingelfinger, published in NEJM ON April 2, 2026. The New England Journal of Medicine just published a sweeping review of GLP-1 receptor agonists, the class of drugs behindContinueContinue reading “The Ozempic Era Grows Up”
